The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 23, 2023

Filed:

Sep. 11, 2020
Applicant:

Vialase, Inc., Aliso Viejo, CA (US);

Inventor:

Ferenc Raksi, Mission Viejo, CA (US);

Assignee:

ViaLase, Inc., Aliso Viejo, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61F 9/008 (2006.01); A61B 3/16 (2006.01); A61F 9/009 (2006.01);
U.S. Cl.
CPC ...
A61F 9/00825 (2013.01); A61B 3/16 (2013.01); A61F 9/009 (2013.01); A61F 9/0084 (2013.01); A61F 2009/00855 (2013.01); A61F 2009/00878 (2013.01); A61F 2009/00882 (2013.01); A61F 2009/00891 (2013.01); A61F 2009/00897 (2013.01);
Abstract

An initial treatment pattern defining an initial volume of ocular tissue to be modified for treating glaucoma is designed. An initial laser treatment is delivered by scanning a laser beam across ocular tissue at an initial placement in the eye in accordance with the initial treatment pattern to thereby photo disrupt the initial volume of ocular tissue. A postoperative measure of intraocular pressure (IOP) is evaluated relative to an IOP criterion to determine if the treatment was successful. If the treatment was not successful, meaning the IOP criterion was not satisfied, then a subsequent treatment pattern that defines a subsequent volume of ocular tissue to be modified, and/or a subsequent placement in the eye is determined. A subsequent laser treatment is delivered by scanning a laser beam across ocular tissue at the subsequent placement within the eye in accordance with the subsequent treatment pattern to thereby photo disrupt the subsequent volume of ocular tissue.


Find Patent Forward Citations

Loading…